AMAG Pharmaceuticals sales and marketing update

AMAG launched Feraheme ferumoxytol injection in the U.S. to treat iron deficiency anemia in adult patients with chronic kidney disease (CKD). A 510 mg vial of the iron replacement therapeutic costs $...